OGT and Integrated Genomics to Develop a Pichia Pastoris Gene Expression Microarray
News Mar 06, 2007
Oxford Gene Technology (OGT) and Integrated Genomics (IG) have announced the signing of a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray.
The collaboration gives OGT access to IG’s proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimised 60 mer oligonucleotide microarray using the ink jet in-situ synthesis (IJISS) platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.
Mr James Clough, Commercial Director at OGT said: “We are delighted to be working with Integrated Genomics. The combination of OGT’s oligonucleotide array expertise combined with Integrated Genomics sequence and detailed Pichia genome annotations will be a powerful molecular research tool for the Pichia community and add strength to our growing portfolio.”
Dr Theresa Walunas, Vice President of Integrated Genomics added: “OGT’s IJISS technology provides an important new capability to the Pichia research community. Microarrays will allow researchers to understand how Pichia’s gene expression changes in response to genetic modifications.”
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019